Trailing-twelve-month (TTM) revenue is $1.11 Billion with a year-over-year growth of +31.40%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $220,779,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-19 |
| Q4 FY2025Period ended 2025-12-31 | $336,657,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-26 |
| Q1 FY2026Period ended 2026-03-31 | $252,086,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-31 |
| Q2 FY2026Period ended 2026-06-30 | $299,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-12 |
| TTM revenue | $1,108,522,000 |
Current P/S: $6,560,806,292 market capitalization ÷ $1,108,522,000 TTM revenue = 5.92x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T16:05:06.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $299.00M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T16:07:46.951Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|
| Fulfillment Services | $149M | $227M | $308M | $402M | $511M |
| Service Fees | $97M | $182M | $262M | $350M | $451M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|
| European Union | $58M | $78M | $93M | $126M | $176M |
| ISRAEL | $1M | $1M | $2M | $3M | $4M |
| Other Countries |
$1.11B
$1.11 Billion
+31.40%
vs. $843.62M a year ago (TTM)
+42.25%
5 Year compound annual growth rate
1 Year
+31.40%
3 Year
+30.70%
5 Year
+42.25%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $962.20M | +$209.43M | +27.82% |
| 2024 | $752.76M | +$182.82M | +32.08% |
| 2023 | $569.95M | +$160.90M | +39.33% |
| 2022 | $409.05M | +$163.78M | +66.77% |
| 2021 | $245.27M | +$108.90M | +79.85% |
| 2020 |
TTM Growth
+31.40%
3-Year CAGR
+30.70%
5-Year CAGR
+42.25%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 22 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T16:07:46.951Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $9M |
| $16M |
| $42M |
| $82M |
| UNITED KINGDOM | $114M | $147M | $174M | $183M | $194M |
|---|
| UNITED STATES | $71M | $174M | $286M | $400M | $507M |
|---|
| $136.38M |
| +$70.52M |
| +107.09% |
| 2019 | $65.85M | +$27.21M | +70.42% |
